All Sites This Site

Find a Program

Find a Lab

MESSAGE FROM THE CHIEF

John P. Roberts, MD


John P. Roberts, M.D.

Professor & Chief,
Division of Transplant Surgery

 

Read message »

Make a Gift

A gift to the Dept of Surgery
helps us discover new
treatments and cures.

 

Read more »

Celebrating 10,000 patients & years of sharing
Transplant Surgery »  Faculty »  Sandy Feng, M.D., Ph.D.

Sandy Feng, M.D., Ph.D.

Associate Professor of Surgery

Director, Abdominal Transplant Fellowship Program

Contact Information

(415) 353-1888 Clinical, Liver

(415) 353-1551 Clinical, Kidney and Pancreas

(415) 353-8725 Academic

fengs@surgery.ucsf.edu

Education

  • Harvard College, B.A., Chemistry, 1979-82
  • Cambridge University, England, Ph.D., Molecular Biology, 1982-85
  • Stanford University School of Medicine, M.D., 1985-90

Residencies

  • Brigham and Women's Hospital, Intern, Surgery, 1990-91
  • Brigham and Women's Hospital, Resident, Surgery, 1991-94
  • Brigham and Women's Hospital, Chief Resident, Surgery, 1994-95

Fellowships

  • University of California, San Francisco, Fellow, Transplant Surgery, 1996-98

Postdoctoral Training

  • Stanford University School of Medicine, Postdoctoral Fellow, Molecular Biology, 1986-88
  • The Whitehead Institute, MIT, Postdoctoral Fellow, Molecular Biology, 1995-96

Board Certification

American Board of Surgery, 1996

Program Affiliations

  • Clinical Fellowship, Division of Transplant
  • Director, Expanded Criteria Donor Kidney Transplant Program, University of California, San Francisco

Clinical Expertise

  • Kidney,  Liver, and Pancreas Transplantation
  • Expanded Criteria Donor Kidney Transplantation
  • MELD Allocation and Living Donor Liver Transplantation
  • Immunosuppression for Liver Transplantation

Research Interests

  • Novel Therapies of Chronic Allograft Dysfunction
  • Immune Suppression With Alemtuzumab and Tacrolimus in Liver Transplantation Patients
  • Immunosuppression Withdrawal for Stable Pediatric Living Donor Liver Transplant Recipients
  • Immunosuppression Withdrawal and Identification of a Profile Predictive of Tolerance
  • Gene Therapy for Transplantation
  • Islet Xenotransplantation: Genetic Approaches to the Problem
  • Defining the Optimal Immunosuppression for Specific Transplant Settings
  • Expanded Criteria Donors

Website LInks

Selected Publications

1.             McTaggart RA, Gottlieb D, Brooks J, Bacchetti P, Roberts JP, Tomlanovich S, Feng S. Sirolimus prolongs recovery from delayed graft function after cadaveric renal transplantation. Am J Transplant. 3: 416-23, Apr/2003.

2.             Fuller TF, Freise CE, Serkova N, Niemann CU, Olson JL, Feng S. Sirolimus delays recovery of rat kidney transplants after ischemia-reperfusion injury. Transplantation. 76: 1594-9, Dec/15/2003.

3.             Brennan TV, Freise CE, Fuller TF, Bostrom A, Tomlanovich SJ, Feng S. Early graft function after living donor kidney transplantation predicts rejection but not outcomes. Am J Transplant. 4: 971-9, Jun/2004.

4.             Feng S, Humar A, Pomfret E, Fishbein T, Gaber O. Surgical challenges in transplantation: the Fourth Annual American Society of Transplant Surgeons' State-of-the-Art Winter Symposium. Am J Transplant. 5: 428-35, Mar/2005.

5.             Feng S, Goodrich NP, Bragg-Gresham JL, Dykstra DM, Punch JD, DebRoy MA, Greenstein SM, Merion RM. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant. 6: 783-90, Apr/2006.

6.             Roayaie K, Feng S. Allocation policy for hepatocellular carcinoma in the MELD era: room for improvement? Liver Transpl. 13: S36-43, Nov/2007.

7.             Lan BY, Landry GM, Tan VO, Bostrom A, Feng S. Ascites in Hepatitis C Liver Transplant Recipients Frequently Occurs in the Absence of Advanced Fibrosis. Am J Transplant. Dec/18/2007.